Lawmaker calls for more rational approach to new drug pricing policy

The government’s unilateral policy to cut the prices of generic prices may increase the use of name-brand medicines rather than cheaper alternatives as the former usually yields higher profit margins for the companies, according to a report released by Yang Seungjo of opposition Democratic Party.

Name-brand drugs generally cost more than generic drugs because marketers have to pay high paten...